Status:
UNKNOWN
Analysis of Risk Factors and Prognosis of Pediatric Patients After Operations for Congenital Heart Disease
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Congenital Heart Disease
Pediatric
Eligibility:
All Genders
Up to 18 years
Brief Summary
This hospital-based retrospective study reviewed patients who underwent surgery for CHD between 2017 and 2020 and analyzed the clinical features and outcomes associated with airway anomalies.
Eligibility Criteria
Inclusion
- all pediatric patients (age \<18 years) who underwent surgery for CHD at our hospital between January 1, 2017, and December 31, 2020.
Exclusion
- with much missing clinical data
Key Trial Info
Start Date :
May 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
999 Patients enrolled
Trial Details
Trial ID
NCT06031831
Start Date
May 15 2022
End Date
December 31 2024
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jenghung Wu
Taipei, Taiwan R., Taiwan, 100229